Skip to main content
OpenTrials
Completed

NCT Number: NCT05080439

Comparative Effects of Two Conservative Treatments in Teres Major in Handball Athletes With Shoulder Pain

The aim of the study is to investigate the effects of the dry needling technique and diacutaneous fibrolysis technique in teres major muscles on pain, range of motion, strength extensibility and muscular properties of the soft tissues of the shoulder in athletes with shoulder pain.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–35 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Sandra Jiménez Jiménez-del-Barrio

Soria, 42004, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Athletes with Shoulder pain
  • Glenohumeral internal rotation deficit
  • Presence of active MTrP in the teres major muscle

Exclusion criteria

  • Previous surgery in the upper limb
  • Previous physiotherapy treatments in the shoulder
  • Dry needling contraindications
  • Previous dry needling experience to mantain the blinding

Treatment and study plan

Diacutaneous Fibrolysis

Other

Application of diacutaneous fibrolysis in teres major

dry needling

Other

Dry needling based on fast-in fast-out technique in the teresa major muscle

Primary outcomes

  1. muscle stiffness

    Time frame: baseline

    the examiners assess the mechanical properties of the fascial and soft tissues with a myoton

  2. muscle stiffness

    Time frame: After treatment immediately "1 hour"

    the examiners assess the mechanical properties of the fascial and soft tissues with a myoton

  3. muscle stiffness

    Time frame: After treatment, one week follow-up

    the examiners assess the mechanical properties of the fascial and soft tissues with a myoton

Secondary outcomes

  1. Pain intensity

    Time frame: Baseline

    the examiners assess the pain intensity using a visual analoigue scale

  2. Pain intensity

    Time frame: After treatment immediately "1 hour"

    the examiners assess the pain intensity using a visual analoigue scale

  3. Pain intensity

    Time frame: After treatment, "one week follow-up"

    the examiners assess the pain intensity using a visual analoigue scale

  4. Range of motion

    Time frame: Baseline

    the examiners assess the shoulder range of motion with an universal goniometer

  5. Range of motion

    Time frame: After treatment immediately "1 hour"

    the examiners assess the shoulder range of motion with an universal goniometer

  6. Range of motion

    Time frame: After treatment, "one week follow-up"

    the examiners assess the shoulder range of motion with an universal goniometer

  7. Extensibility

    Time frame: Baseline

    the examiners assess the extensibility of the posterior part of the tissues of the shoulder using a digital inclinometer

  8. Extensibility

    Time frame: After treatment immediately "1 hour"

    the examiners assess the extensibility of the posterior part of the tissues of the shoulder using a digital inclinometer

  9. Extensibility

    Time frame: After treatment, "one week follow-up"

    the examiners assess the extensibility of the posterior part of the tissues of the shoulder using a digital inclinometer

Sponsors and collaborators

Lead sponsor

Universidad de Zaragoza

Other

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Oct 15, 2021
Registry last updated
Aug 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.